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property of self-renewal, meaning that cell division of a 
stem cell leads again to at least one new stem cell. Not 
surprisingly, as more has become known about how stem 
cells function, their therapeutic potential has been envis-
aged and stem cells have become a research field of major 
interest. Still, in order to use stem cells as a source for tis-
sue repair and cell replacement therapies we first need to 
understand in detail how they fulfill their extraordinary 
functions. Clearly, the processes of differentiation and 
self-renewal require tight coordination and regulation. 
Hence, the elucidation of the genetic programs that are at 
the base of stem cell regulation are of fundamental inter-
est. Furthermore, the question arises of what might hap-
pen if these regulatory programs undergo fatal errors. In-
deed, malformations may occur when stem cells differ-
entiate at the wrong time, in the wrong place or when 
their ability to differentiate or self-renew is unexpectedly 
altered in some way. Especially during development this 
may prove fatal and lead to developmental disorders 
manifesting in a disease. Moreover, there is increasing 
evidence that deregulation of stem cells may lead to ma-
lignancy and produce aggressive cancers  [1] .
 In order to understand the abilities of stem cells we 
need appropriate model systems that allow us to tackle 
our unresolved questions. One of these suitable systems 
is provided by neural crest stem cells (NCSCs), a migra-
tory population of cells that arises during development 
from the dorsal neural tube at the time of neural tube 
closure  [2] . Neural crest cells are of ectodermal origin 
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 Abstract 
 Complex organs like the nervous system are composed of 
different cell types which are all derived from multipotent 
stem cells. In vertebrates, a transient population of stem 
cells, the neural crest, generates the entire peripheral ner-
vous system as well as non-neural progeny. The develop-
mental processes of cellular differentiation and proliferation 
require precise coordination and control. Errors in the pro-
grams that regulate stem cell function can lead to defects 
that manifest in developmental disorders, in some cases 
they might even induce cancer. It is therefore of fundamen-
tal interest to understand the mechanisms of stem cell main-
tenance and differentiation. Using the neural crest as a mod-
el system helps us not only to understand the role of stem 
cells in development but might also lead to new aspects for 
the cure of stem cell-related diseases.  
Copyright © 2007 S. Karger AG, Basel
 
 Introduction 
 Stem cells are the source of all cell types that exist in 
our bodies. Stem cells are usually defined in terms of two 
characteristics: first, the ability to produce several types 
of differentiated progeny (multipotency) and second, the 
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and only exist in vertebrates. Their appearance in evolu-
tion is not fully understood, but because of their signifi-
cant contribution to the cellular diversity in vertebrates 
and their unique features some might consider the neural 
crest as an addition to the three germ layers, ectoderm, 
mesoderm and endoderm  [3] . NCSCs can give rise to 
both, neural and non-neural structures. For example, 
most cells of the peripheral nervous system, e.g. sensory 
neurons in the dorsal root ganglia, sympathetic and para-
sympathetic neurons of the autonomic nervous system, 
chromaffin cells of the adrenal gland and the enteric ner-
vous system of the gut are all of neural crest origin. Non-
neural cells comprise melanocytes (the pigment cells of 
the skin), smooth muscle cells of the heart outflow tract 
and cranial blood vessels and craniofacial bone and car-
tilage. This large variety of cells that arise from NCSCs 
makes them a highly interesting source to investigate 
how cellular diversity is achieved. Several model organ-
isms are commonly used in neural crest research. The 
most common are zebra fish, chicken, rat and mouse, 
while quail-chick chimeras have been proven useful for 
cell grafting experiments  [4–6] . The development of in 
vitro  systems, such as for example neural tube explant 
cultures, that allow the cultivation of pure NCSC popula-
tions, significantly contributed to the field of stem cell 
research  [7] . Altogether, the neural crest serves as a valu-
able model system for a range of developmental process-
es, including induction, specification and differentiation, 
as well as guided cell migration and epithelial-to-mesen-
chymal transition  [8, 9] .
 In the following we will summarize current knowl-
edge regarding some of the factors that regulate NCSCs, 
findings that may be fundamental on the way to thera-
peutic applications of stem cells. We will approach the 
link between the neural crest and certain diseases, show-
ing the molecular and cellular events that may lead to a 
specific disease. Finally we will evaluate current knowl-
edge concerning neural crest-derived tumors, whether 
NCSCs might be at the origin of certain cancers, and how 
this might suggest new ideas for cancer therapies.
 Factors Regulating NCSCs 
 Neural crest cells arise at the border of neural plate and 
epidermis at the time of neural tube closure  [8] . Follow-
ing the folding process and neural tube closure neural 
crest precursors are localized in the dorsal part of the 
neural tube. There they undergo an epithelial-to-mesen-
chymal transition and detach from the neural tube in a 
process called delamination. They acquire unique fea-
tures that distinguish them from their tissue of origin 
and begin to migrate extensively throughout the embryo. 
Significant progress has been made in identifying the 
mechanisms leading to the induction and specification of 
the neural crest. We will only outline the factors involved 
in these steps and refer the interested reader to already 
existing reviews that give more detailed information  [8, 
10] .
 One of the early inductive signals, BMP4, is expressed 
in the border region of the epidermis and the neural plate. 
It was shown that BMP has a dose-dependent effect dur-
ing neural crest induction. Indeed, high levels of BMP 
give rise to epidermis, intermediate levels to neural crest 
and low levels to neural tissue  [8] . In addition to BMP, the 
WNT signaling pathway plays a major role in neural crest 
induction. Gain and loss of function experiments with 
members of the WNT signaling pathway have established 
a requirement for WNT signaling in the induction of the 
neural crest  [11–13] . The actions of early inducing sig-
nals trigger the activation of transcription factors in the 
prospective neural crest leading to further specifica-
tion. Among these are AP-2, FOXD3, SLUG and SNAIL, 
c-MYC, RHOB, ZIC-family and SOXE transcription fac-
tors (SOX8, SOX9 and SOX10)  [9, 10] .
 Interestingly some of the factors that act during early 
neural crest induction and specification will later on play 
a role in cell fate decisions of the neural crest. SOX9 seems 
to be required during early neural crest formation, is 
down-regulated in migratory NCSCs, but is again ex-
pressed in neural crest progenitors that form craniofacial 
structures  [14, 15] . The same is true for canonical WNT 
signaling and the BMP pathway. While both have an ‘ear-
ly’ role in neural crest induction, they will at a later time-
point have instructive roles in cell fate specification of 
multipotent neural crest cells, as we will see in the follow-
ing paragraph.
 Following delamination neural crest cells migrate via 
defined pathways to various locations to contribute to di-
verse tissues. During and after migration they undergo 
specific differentiation steps which are influenced by en-
vironmental signals ( fig. 1 ). Again BMP signaling plays 
an important role. More precisely, BMP2 acts as a growth 
factor and instructs NCSCs to become autonomic neu-
rons of the peripheral nervous system  [16] . In addition, 
canonical WNT signaling acts instructively to promote 
sensory neurogenesis from NCSCs  [17, 18] . The role of 
canonical WNT signaling in cell fate specification of 
neural crest cells contrasts with its known function in 
stem cells from other tissues: in embryonic, intestinal, 
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skin and hematopoietic stem cells, WNTs mainly regu-
late proliferation of the respective stem cell pools and do 
not influence fate specification  [19] . This suggests that 
responsiveness to WNTs depends on cell-intrinsic fea-
tures and the environmental context. It also clearly sepa-
rates the behavior of NCSCs in the presence of WNT 
 signaling from that of other types of stem cells. Interest-
ingly, the simultaneous action of WNT and BMP 
signaling on NCSCs does not induce one particular cell 
fate, but rather keeps these cells in a nondifferentiated 
multipotent state  [20] . Other instructive factors that are 
involved in neural crest differentiation are glial growth 
factor neuregulin (NRG), which is required for periph-
eral gliogenesis and transforming growth factor-  (TGF-
  ) signaling, which induces non-neuronal fates, for ex-
ample smooth muscle cells  [2] .
 The transcription factor SOX10, a member of the SRY-
related high mobility group (HMG) of proteins, fulfills a 
dual role in the neural crest. During the early phase of 
migration SOX10 is expressed in all NCSCs, whereas lat-
er its expression is mainly restricted to cells of the glial 
lineage  [21] . In addition to its role in gliogenesis, studies 
have demonstrated a requirement for SOX10 to maintain 
multipotency of migratory and postmigratory NCSCs. 
SOX10 keeps NCSCs responsive to instructive growth 
factors that induce different cell lineages  [22, 23] . Fur-
thermore, lack of SOX10 leads to increased apoptosis in 
undifferentiated postmigratory neural crest cells  [22] .
 It may appear surprising that a relatively small number 
of signaling molecules are sufficient to control the diverse 
phenomena of stem cell maintenance and their fate deci-
sions. Possibly combinations of these signals have syner-
gistic or antagonistic effects on one another, creating a 
network of possible inputs on stem cells. Cellular re-
sponse to these signals may further depend on the local 
environment of the cell, where the extracellular matrix 
and neighboring cells influence the cellular interpreta-
tion of instructive signals.
 Neural Crest in Human Congenital Diseases 
 With the neural crest contributing to a variety of tis-
sues and organs it is not surprising that it is also of clini-
cal relevance. In fact, developmental abnormalities of the 
neural crest are implicated in several congenital diseases, 
called neurocristopathies. These may be caused by muta-
tions that affect NCSC function. Such links between mo-
lecular events of stem cell regulation and disease are of 
particular interest as they may serve to better understand 
both developmental regulation and disease mechanism. 
One good example is Hirschsprung’s disease (HSCR), 
also called aganglionic megacolon, a relatively common 
neurocristopathy affecting the enteric nervous system. 
Patients with HSCR show absence of enteric ganglia 
(agangliosis) along a variable length of the intestine, with 
the distal part of the gut being most often affected. HSCR 
manifests itself in chronic constipation, as a lack of in-
nervation impairs gut motility and enzyme secretion into 
the intestinal lumen. In HSCR, enteric progenitor cells 
(EPCs) fail to completely colonize the gut. Normal EPCs 
are self-renewing and multipotent, giving rise to diverse 
neurons and glia of the enteric nervous system, and per-
sist in the adult organism  [24–26] . Known causes of in-
complete colonization are either premature differentia-
tion or impaired migration of EPCs  [24, 27] . The prima-
ry genes affected in HSCR are indeed required for proper 
EPC development and function. Among these are the re-
ceptor-tyrosine kinase (RET), endothelin receptor type B 
(EDNRB), endothelin 3 (EDN3), glial cell line-derived 
neurotrophic factor (GDNF), SOX10 and others such as 
endothelin converting enzyme 1 (ECE1) or smad inter-
WNT/ BMP
WNT
BMP TGF
NRG
autonomic
neuron smooth
muscle cell glia cellsensory
neuron
 Fig. 1. NCSC response to instructive signals. The combination of 
WNT and BMP signaling maintains NCSCs in a multipotent 
state. WNT signaling alone instructs NCSCs to induce sensory 
neurogenesis and BMP signaling alone induces autonomic neu-
rogenesis. Glial differentiation is induced by NRG, while non-
neural differentiation, i.e. into smooth muscle cells, requires 
TGF-  signaling. 
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acting protein 1 (SIP1). GDNF acts as a chemoattractant 
and promotes proliferation and survival of enteric neural 
crest cells in vitro  [28] . The GDNF receptor RET, how-
ever, is specifically expressed in EPCs and is necessary for 
their migration and survival in the gut  [27, 29] . Mutations 
in RET are among the most common in HSCR patients. 
EPCs that carry a heterozygous mutation in the tran-
scription factor SOX10 initially show normal migration 
into the proximal intestine. While their survival capacity 
remains unaffected, these cells are unable to maintain 
their progenitor state, leading to premature differentia-
tion and hence to a reduction of the progenitor cell pool 
size  [24] . This depletion then causes incomplete coloniza-
tion of the more distal gut ( fig. 2 ). Further confirmation 
comes from a recent study showing that SOX10 overex-
pression inhibits neuronal and glial differentiation of 
ENS progenitors without affecting their multipotency 
 [30] . The authors also addressed the function of EDN3 in 
enteric nervous system development. The data indicates 
that EDN3 is needed for the maintenance of EPCs. EDN3 
is a ligand for EDNRB, a receptor found to be mutated in 
HSCR patients  [31, 32] . Whether the requirement for 
EDNRB in enteric nervous system development concerns 
migration or maintenance of enteric precursors has not 
been clarified so far.
 Other neurocristopathies can also affect non-neural 
derivatives of the neural crest. Promotion of non-neural 
lineages in NCSCs largely depends on TGF-  signaling. 
Indeed, mice lacking the TGF-  type II receptor in neu-
ral crest cells show disorders of eye development and ad-
ditionally display a phenotype resembling DiGeorge syn-
drome, characterized by anomalies in the development of 
craniofacial bone and cartilage, the outflow tract of the 
heart, as well as thymus and parathyroid glands  [33, 
34] .
 Taking the example of the enteric nervous system de-
velopment, it appears that neural crest cells have to inte-
grate a variety of intrinsic and extracellular signals. These 
processes conceivably involve interactions between dis-
tinct factors. Unraveling these interactions between al-
ready established and yet unknown regulators will be an 
important step for the further understanding of develop-
mental and disease mechanisms.
 Neural Crest in Cancer 
 Tumors are characterized by uncontrolled prolifera-
tion of tissue that does not serve a physiological function. 
They usually show a heterogeneous cellular composition; 
indeed not all cells within a tumor have the same malig-
distal
proximal
distal
proximal
normal ENS
development
impaired colonization
 leading to agangliosis
distal
proximal
distal
proximalA
B
RET: survival
GDNF: survival, proliferation, migration
SOX10: maintenance
EDN3: maintenance
 Fig. 2. A simplified model of gut coloniza-
tion by enteric nervous system precursor 
cells.  A EPCs migrate along the gut in 
proximal to distal direction. EPCs colo-
nize the entire intestine and differentiate 
into the cells of the enteric nervous system. 
 B Mutations in important regulatory genes 
lead to impaired EPC colonization of the 
gut. As a result, innervation of the gut is 
incomplete. 
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nant potential. This may appear surprising as many tu-
mors have a clonal origin. So what is the origin of this 
heterogeneity? Recent reports have established the con-
cept of a cancer-initiating cell (or cancer stem cell) that 
has the potential to initiate and form tumors  [35–38] . In 
analogy to a normal stem cell, such a cancer stem cell can 
self-renew and undergo multilineage differentiation, giv-
ing rise to more benign progeny with limited proliferative 
potential ( fig. 3 ). While the benign progeny cells com-
pose the major part of the tumor, a relatively small num-
ber of proliferative cancer stem cells are sufficient to 
cause aggressive tumor growth. These findings open up 
new perspectives for cancer therapies as it might be more 
efficient to target a specific cell population within a tu-
mor instead of assuming the tumor to be functionally 
homogeneous. Data on molecular and cellular analysis of 
tumor biology might need to be reviewed in the light of 
these findings, as many studies have simply addressed 
tumors as a single entity. Identification of a specific sub-
set of cells in a tumor requires availability of suitable 
markers. For example, in the case of medullo- and glio-
blastomas, aggressive cancers of the central nervous sys-
tem, the marker CD133 was successfully used to isolate a 
population of malignant cells with tumor-initiating po-
tential. Moreover these cells showed features reminiscent 
of neural stem cells  [36] . In the case of breast cancer, an 
epithelial tumor, a fraction of cells expressing CD44 but 
little or no CD24 (CD44+CD24–/low) showed sustained 
tumor initiation and growth by serial passaging in a xe-
notransplantation assay. Furthermore, these cells also 
generated populations of nontumorigenic cells with dif-
ferent marker expression  [35] .
 The question arises as to where these cancer stem cells 
originate. Several theories exist, assuming that mutations 
in somatic stem cells might cause these cells to exit from 
tight proliferation control. More restricted progenitor or 
differentiated cells might acquire malignant stem cell 
properties through mutations. Also, cell fusion events 
which normally occur in development, e.g. in muscle for-
mation, might be a source of cancer, as fusion events 
might generate cells with malignant properties  [39] . In 
any case, the influence of the cellular environment should 
be considered as an additional trigger for the appearance 
and dissemination of cancer stem cells.
 With the extensive contribution of neural crest cells to 
the vertebrate body, several tumors can be assigned to a 
neural crest origin. Among these are melanoma, skin tu-
mors which arise from melanocytes, neuroblastoma, a 
cancer of sympathoadrenal cells and pheochromocyto-
ma, tumors of chromaffin cells of the adrenal medulla or 
extra-adrenal paraganglia. Might the concept of tumor 
appearance through cancer stem cells also apply to neu-
ral crest-derived tumors?
 In a recent study a subpopulation of cells was found in 
metastatic melanomas, which could differentiate in vitro 
into cells reminiscent of some neural crest lineages. These 
cells might thus have similarities to neural crest stem or 
progenitor cells, although this has not yet been analyzed 
 [40] . Moreover, upon transplantation of labeled adult hu-
man metastatic melanoma cells in ovo  into the premigra-
tory neural crest of chicken embryos, melanoma cells dis-
tributed along neural crest migratory pathways. They 
seemed to have lost their tumorigenic potential and par-
tially acquired normal neural crest features. The authors 
conclude that reprogramming through the embryonic 
microenvironment occurred  [41] . Although this is no 
proof of any involvement of NCSCs in melanoma forma-
tion it is interesting that melanoma cells are able to adopt 
characteristics of non-pigment neural crest derivatives.
 Neuroblastomas are among the most common pediat-
ric tumors. They arise from precursor cells of the neural 
crest-derived sympathoadrenal lineage. Neuroblastoma 
is often characterized by an enigmatic clinical behavior: 
these tumors may regress spontaneously, especially when 
occurring before 1 year of age. However, aggressive tu-
mor growth and metastatic disease are often observed 
when neuroblastoma is diagnosed after 1 year of age. It is 
still unclear whether favorable and unfavorable neuro-
blastomas arise from a common precursor or if they rath-
er have distinct origins. The occurrence of neuroblasto-
malignant cancer stem cell with
tumor initiating capacity
benign cancer stem cell progeny without
tumor initiating capacity
 Fig. 3. Tumor initiation and growth can be driven by cancer stem 
cells. Besides their malignant proliferative potential, these cells 
are able to self-renew and to give rise to benign progeny cells that 
represent the major part of the tumor. Benign cancer cells show 
reduced proliferative potential and are not able to induce tumors 
de novo. 
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 It is tempting to speculate that cancer stem cells might 
be a source for at least some cases of neural crest tumors. 
To clarify this point it is necessary to better define the 
cellular composition of neural crest-derived tumors, such 
as melanomas and neuroblastomas mentioned here. De-
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ogy of tumorigenesis in neural crest cells. Thus, detailed 
analysis of the mechanisms regulating NCSC fates dur-
ing development and disease may be worthwhile goals on 
the way to establish novel anticancer treatments.
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